Transitional Cell Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Transitional Cell Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Tesetaxel for Previously Treated Patients With Bladder Cancer [Phase 2]
Phase 2 clinical trial update for Tesetaxel in previously treated bladder cancer (transitional cell carcinoma) patients; the trial status is…
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder [Phase 1]
Phase 1 study evaluating Mycobacterium w in patients with BCG-refractory superficial transitional cell carcinoma of the bladder has been com…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer [EARLY_Phase 1]
Early-phase trial evaluating mitomycin C with hyperthermia and intravesical mitomycin C for recurrent bladder cancer has completed, with res…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder [Phase 1]
This entry reports the completion of a Phase I trial evaluating suramin for superficial transitional cell carcinoma of the bladder.
-
CLINICAL_TRIALS trial_result · 2006-09-27Clinical Trial Update: Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer [Phase 3]
Phase 3 trial comparing adjuvant versus progression-triggered gemcitabine monotherapy for locally advanced bladder cancer; trial status is c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-08-29Clinical Trial Update: Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating sequential gemcitabine and cisplatin followed by pemetrexed and gemcitabine in patients with advanced or metastat…
-
CLINICAL_TRIALS trial_result · 2006-06-22Clinical Trial Update: Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder [Phase 2]
A completed Phase 2 trial evaluated intravesical epirubicin plus BCG for preventing recurrence in patients with transitional cell carcinoma …